![](https://investorshub.advfn.com/uicon/33511.png?cb=1696427377)
Friday, March 10, 2017 7:47:31 PM
John,
Thank you and it is a pleasure to meet you.
We are currently putting together the strategy for the firm to get current.
Steven D. Spence
Managing Director - Investment Banking
Dominick & Dickerman LLC
570 Lexington Ave., Suite 4200
New York, New York 10022
Direct:
Cell:
Email:
Founded 1870 | FINRA and SIPC
--------------------------------------------------------------------------------
From: _________@aol.com
Sent: Thursday, March 9, 2017 6:33:10 AM
To: Steven Spence
Subject: Re: Amarantus BioSciences
Stephen,
Congratulations on your new position as Board of Directors with the new venture between SeD and Amarantus.
I am a shareholder in AMBS, and was wondering when they might update their delinquent SEC filings?
Many thanks, JP
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM